Alexandria Real Estate (ARE)

Medical Office | Lab Space/ Research

Alexandria Real Estate (ARE) is tracked in the Hoya Capital REIT and real estate database, classified under Medical Office, Lab Space with a Lab Space/ Research focus. The company came public in 1997. It is categorized as a Mid-Cap name in the database. The company has an equity market capitalization of approximately $8.4 billion. Shares recently traded near $46.21 with a dividend yield of about 6.23 percent. The company pays dividends on a quarterly schedule with a forward annual dividend rate of $2.88 per share. Its FFO payout ratio is roughly 40 percent. The dividend was reduced by about 33.8 percent over the past year. The stock is priced at roughly 7.9 times estimated 2026 funds from operations. Balance sheet leverage stands near 5.8 times debt to EBITDA. S&P rates the company's credit at BBB+. Within Hoya Capital's index sector framework the company is grouped under Healthcare. Moody's rates the company's credit at Baa2. The next scheduled ex-dividend date on file is 2026-09-30. It operates with an internal management structure. This profile includes fundamentals, dividend history, valuation metrics, and sector rankings from Hoya Capital's research database, refreshed on a regular schedule.

Alexandria Real Estate Equities, Inc. is an American real estate investment trust that invests in office buildings and laboratories leased to tenants in the life science and technology industries.

Use the REIT directory to compare Alexandria Real Estate with its peers, or explore the sector research hub for the themes driving the broader property sector.

Company website: www.are.com